This could be why your weight-loss medication isn’t delivering results

Fox News — Apr 16, 11:00 AM

A study in Nature found a specific genetic variant that may boost the effectiveness of GLP-1 weight-loss drugs like semaglutide and tirzepatide.

Read full article at Fox News →

Lilly Seeks FDA Nod for Pill

Lilly to seek FDA nod for obesity pill in diabetes after late-stage trial win Seeking Alpha — Apr 16, 11:21 AM
Hims & Hers Health Stock Rallies on Regulatory Pivot. It’s Not About GLP-1s This Time. Barrons — Apr 16, 12:46 PM
Public health plans should cover Mounjaro for type 2 diabetes, Canada’s Drug Agency recommends The Globe and Mail — Apr 16, 11:00 AM
Hims & Hers on track to extend gains as RFK Jr. seeks to loosen peptide regulations Seeking Alpha — Apr 16, 09:15 AM